Our proprietary GPCR-based drug discovery technologies are at the core of our research programs, enabling us to internally discover drug candidates. In addition to drug candidates currently in development, we have maintained an extensive research effort across several therapeutic areas with large market opportunities.

Our drug candidates have not been approved by the U.S. Food and Drug Administration or any other regulatory agency.